ODYY · Odyssey Health, Inc. · Insider Trading

The options vest 50,000 immediately; 50,000 vest on July 31, 2024; 50,000 vest on October 31, 2024; 50,000 vest on January 31, 2025; and 50,000 vest on April 30, 2025.

The options vest 100,000 immediately; 100,000 vest on July 31, 2024; 100,000 vest on October 31, 2024; 100,000 vest on January 31, 2025; and 100,000 vest on April 30, 2025.

The options vest 100,000 immediately; 100,000 vest on July 31, 2024; 100,000 vest on October 31, 2024; 100,000 vest on January 31, 2025; and 100,000 vest on April 30, 2025.

The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025.

The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025.

The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024.

The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024.

The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023

No expiration date

No expiration date

No expiration date

No expiration date

No expiration date

No expiration date

No expiration date

Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.

Vesting Schedule 250,000 upon signing; 250,000 upon an IND being approved by the FDA for Phase 2; 250,000 upon a listing on a national exchange (Nasdaq, NYSE); and 250,000 one year from Effective Date.

500,000 vesting upon a listing on a higher exchange (OTCQB, Nasdaq or NYSE)

Shares gifted are 500,000 shares of common stock gifted to Sean M Redmond; 500,000 shares of common stock gifted to Conor J. Redmond; 500,000 shares of common stock gifted to Devin P. Redmond.

Vesting Schedule: 50% vest on first dosed subject of Phase 2 Trial; 50% on last dosed subject of Phase 2 Trial.

The vesting of the RSU (Units) is as follows: 500,000 RSU vest equally over 12 months, subject to the Grantee's continuous service through the applicable vesting date. If not forfeited, vesting of the Units will be accelerated and will vest in full immediately upon the closing of a Corporate Transaction, provided that Grantee provides Continuous Service to the Company through the date such Corporate Transaction is closed. Vested Units will be settled by delivering to Grantee a number of shares equal to the number of vested Units on the earlier of the date on which the Grantee's Continuous Service ends, or the closing of a Corporate Transaction.

No expiration.

The vesting of the RSU (Units) is as follows: 500,000 RSU vest equally over 12 months, subject to the Grantee's continuous service through the applicable vesting date. If not forfeited, vesting of the Units will be accelerated and will vest in full immediately upon the closing of a Corporate Transaction, provided that Grantee provides Continuous Service to the Company through the date such Corporate Transaction is closed. Vested Units will be settled by delivering to Grantee a number of shares equal to the number of vested Units on the earlier of the date on which the Grantee's Continuous Service ends, or the closing of a Corporate Transaction.

No expiration.

The vesting of the RSU (Units) is as follows: 500,000 RSU vest equally over 12 months, subject to the Grantee's continuous service through the applicable vesting date. If not forfeited, vesting of the Units will be accelerated and will vest in full immediately upon the closing of a Corporate Transaction, provided that Grantee provides Continuous Service to the Company through the date such Corporate Transaction is closed. Vested Units will be settled by delivering to Grantee a number of shares equal to the number of vested Units on the earlier of the date on which the Grantee's Continuous Service ends, or the closing of a Corporate Transaction.

No expiration.

Vesting schedule: 250,000 shares vest on signing of closing documents; 250,000 shares vest on Phase 1a first dosing of human; 250,000 shares vest on Phase 1b first dosing of human; and 250,000 shares vest upon Company being accepted on NASDAQ.

The vesting of the RSU (Units) is as follows: 3,000,000 RSU vesting equally over 36 months, subject to the Grantee's continuous service through the applicable vesting date. If not forfeited, vesting of the Units will be accelerated and will vest in full immediately upon the closing of a Corporate Transaction, provided that Grantee provides Continuous Service to the Company through the date such Corporate Transaction is closed. Vested Units will be settled by delivering to Grantee a number of shares equal to the number of vested Units on the earlier of the date on which the Grantee's Continuous Service ends, or the closing of a Corporate Transaction.

No expiration.

The vesting of the RSU (Units) is as follows: 1,000,000 RSU vesting equally over 36 months, subject to the Grantee's continuous service through the applicable vesting date. If not forfeited, vesting of the Units will be accelerated and will vest in full immediately upon the closing of a Corporate Transaction, provided that Grantee provides Continuous Service to the Company through the date such Corporate Transaction is closed. Vested Units will be settled by delivering to Grantee a number of shares equal to the number of vested Units on the earlier of the date on which the Grantee's Continuous Service ends, or the closing of a Corporate Transaction.

No expiration.

Options not earned or vested and cancelled September 16, 2020

No expiration.